Actively Recruiting

Phase Not Applicable
Age: 0 - 5Years
All Genders
Healthy Volunteers
NCT06311162

Early Life Intervention in Pediatrics Supported by E-health - SMOKE

Led by Insel Gruppe AG, University Hospital Bern · Updated on 2026-05-06

160

Participants Needed

1

Research Sites

242 weeks

Total Duration

On this page

Sponsors

I

Insel Gruppe AG, University Hospital Bern

Lead Sponsor

U

University of Bern

Collaborating Sponsor

AI-Summary

What this Trial Is About

Unrestricted parental smoking habits are lifestyle risk behaviors associated with chronic, systemic inflammation, which promotes the pathogenesis of non-communicable diseases (NCDs). Exposure to secondhand tobacco smoke in early life contributes to the development of specific NCDs in children, i.e. asthma. Early preventive measures to improve lifestyle behavior in parents are therefore of utmost importance. The aim of ELIPSE-II is to assess whether an eHealth application intervention for parents is feasible and efficacious in lowering levels of urinary cotinine as a measure of second-hand smoke exposure in their children .

CONDITIONS

Official Title

Early Life Intervention in Pediatrics Supported by E-health - SMOKE

Who Can Participate

Age: 0 - 5Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Child younger than 6 years old
  • Child exposed to second-hand smoke at home (at least one parent smoking)
  • Parent speaks German
  • All sexes and ethnic backgrounds eligible
  • Signed informed consent from parent
  • Child lives in the same household as participating parent
  • Child referred by a healthcare professional (physician, midwife, nurse, or others)
Not Eligible

You will not qualify if you...

  • Currently participating in another study targeting similar outcomes
  • Participating in an active smoking cessation program

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Department of Paediatrics, Inselspital, Bern University Hospital

Bern, Switzerland, 3010

Actively Recruiting

Loading map...

Research Team

M

Matthias V. Kopp, Prof. Dr.

CONTACT

J

Julian Jakob, Dr.

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here